Assessment of Stool DNA Markers to Detect Colorectal Neoplasia in Patients with Inflammatory Bowel Disease: A Multi-site Case-control Study

BACKGROUND AND AIMS: The FDA-approved multitarget stool-DNA [mt-sDNA] test is a successful colorectal cancer [CRC] screening tool in average-risk individuals but is not indicated for patients with inflammatory bowel disease [IBD]. We determined the performance of the mt-sDNA assay without the haemog...

Descripción completa

Detalles Bibliográficos
Autores principales: Itzkowitz, Steven, Farraye, Francis A, Limburg, Paul J, Gagrat, Zubin, Olson, Marilyn C, Zella, Julia, Kisiel, John B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588779/
https://www.ncbi.nlm.nih.gov/pubmed/37166153
http://dx.doi.org/10.1093/ecco-jcc/jjad069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588779/
https://www.ncbi.nlm.nih.gov/pubmed/37166153
http://dx.doi.org/10.1093/ecco-jcc/jjad069

Ejemplares similares